CEBP Susan G. Komen for the Cure-AACR Outstanding Investigator Award for Breast Cancer Research Translational Cancer Medicine 2008: Cancer Clinical Trials and Personalized Medicine
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by McTiernan, A.
Right arrow Articles by Bowen, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McTiernan, A.
Right arrow Articles by Bowen, D.
Cancer Epidemiology Biomarkers & Prevention Vol. 8, 201-207, March 1999
© 1999 American Association for Cancer Research


Commentary

Exercise Clinical Trials in Cancer Prevention Research:A Call to Action

Anne McTiernan1, Robert S. Schwartz, John Potter and Deborah Bowen

Cancer Prevention Research Program, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109 [A. M., J. P., D. B.], and Division of Geriatrics, Department of Medicine, University of Washington School of Medicine, Seattle, Washington 98195 [R. S. S.]

Abstract

The experimental study design can yield valuable information in measuring the association between physical activity and occurrence of cancers. Randomized clinical exercise trials can provide insight into the avenues through which physical activity might affect cancer development and can provide experience with diffusing an exercise intervention into certain populations. This report describes the potential utility of the randomized clinical trial design in providing answers about bias, mechanisms, behavior change, and dose-response in defining the causal pathway between physical activity and cancer. The challenges and limitations of exercise clinical trial are discussed. The research experience in cardiovascular disease and exercise is used as a model for developing a research agenda to explore the potential role of physical activity as a cancer-prevention modality. We recommend that a series of small clinical trials of exercise interventions be conducted to measure exercise change effects on biomarkers for cancer risk, to learn about exercise behavior change in individuals at risk for cancer, and to serve as feasibility studies for larger randomized controlled trials of cancer and precursor end points and for community intervention studies.




This article has been cited by other articles:


Home page
J. Epidemiol. Community HealthHome page
C I Cornelio, M Garcia, A Schiaffino, J M Borres, F J Nieto, E Fernandez, and for the CHIS.FU Study Group
Changes in leisure time and occupational physical activity over 8 years: the Cornelle Health Interview Survey Follow-Up Study
J. Epidemiol. Community Health, March 1, 2008; 62(3): 239 - 244.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
K. H. Schmitz, R. L. Ahmed, P. J. Hannan, and D. Yee
Safety and Efficacy of Weight Training in Recent Breast Cancer Survivors to Alter Body Composition, Insulin, and Insulin-Like Growth Factor Axis Proteins
Cancer Epidemiol. Biomarkers Prev., July 1, 2005; 14(7): 1672 - 1680.
[Abstract] [Full Text] [PDF]


Home page
Mol. Interv.Home page
X. Peng, B. Chen, C. C. Lim, and D. B. Sawyer
The Cardiotoxicology of Anthracycline Chemotherapeutics: TRANSLATING MOLECULAR MECHANISM INTO PREVENTATIVE MEDICINE
Mol. Interv., June 1, 2005; 5(3): 163 - 171.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
A. Rundle
Molecular Epidemiology of Physical Activity and Cancer
Cancer Epidemiol. Biomarkers Prev., January 1, 2005; 14(1): 227 - 236.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
M. R. Zielinski, M. Muenchow, M. A. Wallig, P. L. Horn, and J. A. Woods
Exercise delays allogeneic tumor growth and reduces intratumoral inflammation and vascularization
J Appl Physiol, June 1, 2004; 96(6): 2249 - 2256.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
A. McTiernan, E. White, and C. Kooperberg
Exercise and Risk of Breast Cancer--Reply
JAMA, December 24, 2003; 290(24): 3193 - 3193.
[Full Text] [PDF]


Home page
J. Nutr.Home page
C. M. Friedenreich and M. R. Orenstein
Physical Activity and Cancer Prevention: Etiologic Evidence and Biological Mechanisms
J. Nutr., November 1, 2002; 132(11): 3456S - 3464.
[Abstract] [Full Text] [PDF]


Home page
CA Cancer J ClinHome page
H. J. Eyre
Nutritional Advice for Cancer Survivors
CA Cancer J Clin, May 1, 2001; 51(3): 151 - 152.
[Full Text] [PDF]


Home page
CA Cancer J ClinHome page
J. Brown, T. Byers, K. Thompson, B. Eldridge, C. Doyle, A. M. Williams, and American Cancer Society Workgroup on Nutrition and
Nutrition During and After Cancer Treatment: A Guide for Informed Choices by Cancer Survivors
CA Cancer J Clin, May 1, 2001; 51(3): 153 - 181.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
C. M. Friedenreich
Physical Activity and Cancer Prevention: From Observational to Intervention Research
Cancer Epidemiol. Biomarkers Prev., April 1, 2001; 10(4): 287 - 301.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation
Copyright © 1999 by the American Association for Cancer Research.